BioXcel Therapeutics to Present at Jefferies Global Healthca

28.05.2024 - NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) - BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced ... Seite 1

Related Keywords

New York , United States , Vimal Mehta , Vincentj Oneill , Product Development , Drug Administration , Bioxcel Therapeutics Inc , Nasdaq , Xcel Therapeutics , Jefferies Global Healthcare Conference , Bioxcel Therapeutic , Executive Vice President , Bioxcel Therapeutics , Breakthrough Therapy , Fast Track ,